Literature DB >> 9144489

Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene.

D A Grillot1, M González-García, D Ekhterae, L Duan, N Inohara, S Ohta, M F Seldin, G Nuñez.   

Abstract

The bcl-x gene, a bcl-2 family member, is highly regulated during lymphoid development, and its expression modulates apoptosis in lymphoid and other cell populations. Several forms of bcl-x mRNAs with different biologic functions have been described in rodents and humans. In this study, we have determined the organization and promoter region of the mouse bcl-x gene in an effort to understand the molecular basis for the different bcl-x mRNA species identified in tissues. We show that mouse bcl-x maps to the distal mouse chromosome 2 at approximately 89 cM, and exhibits a three-exon structure with an untranslated first exon and a facultative first intron. The coding region of bcl-xL is generated by the juncture of exons II and III through a splicing reaction, whereas bcl-xS is generated by an alternatively utilized donor splice site located within exon II. Analysis of multiple cDNAs and primer extension experiments revealed major transcription initiation sites in brain and thymus within a GC-rich region, with multiple Sp1-binding motifs located upstream of exon I. Another promoter was mapped to a 57-bp region localized upstream of the translation initiation codon by transfection of reporter constructs into FL5.12 and K562 cell lines. The remarkable similarity between the genomic regions of bcl-2 and bcl-x suggests that these genes have evolved from a common ancestral gene or through gene duplication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144489

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 2.  One path to cell death in the nervous system.

Authors:  J Glasgow; R Perez-Polo
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

3.  A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.

Authors:  K L Sugars; V Budhram-Mahadeo; G Packham; D S Latchman
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

4.  ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.

Authors:  J L Smith; A E Schaffner; J K Hofmeister; M Hartman; G Wei; D Forsthoefel; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 6.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

7.  Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis.

Authors:  Junghee Lee; Mari Kannagi; Robert J Ferrante; Neil W Kowall; Hoon Ryu
Journal:  FASEB J       Date:  2009-01-29       Impact factor: 5.191

8.  A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.

Authors:  Yan Yan; Leuyen Phan; Fan Yang; Moshe Talpaz; Yu Yang; Zeyu Xiong; Bernard Ng; Nikolai A Timchenko; Catherine J Wu; Jerome Ritz; Hong Wang; Xiao-Feng Yang
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

9.  Transcription elongation factor S-II is required for definitive hematopoiesis.

Authors:  Takahiro Ito; Nagisa Arimitsu; Masaki Takeuchi; Nobuyuki Kawamura; Makiko Nagata; Kayoko Saso; Nobuyoshi Akimitsu; Hiroshi Hamamoto; Shunji Natori; Atsushi Miyajima; Kazuhisa Sekimizu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.